Cold News and Research

RSS

A novel method for 3D printing of milk-based products

Researchers from the Singapore University of Technology and Design (SUTD) developed a method to perform direct ink writing (DIW) 3D printing of milk-based products at room temperature, while maintaining its temperature sensitive nutrients.

19 Sep 2020

Johns Hopkins professor to study how climate and environmental elements influence the spread of COVID-19

Ben Zaitchik, a professor of Earth and planetary sciences at Johns Hopkins University, is available to speak with the media about the vigorous research still needed to definitively determine if and how climate, environmental and meteorological elements influence the spread of COVID-19.

16 Sep 2020

Climate change could shift the spread of West Nile virus

West Nile virus spreads most efficiently in the US at temperatures between 24-25 degrees Celsius (75.2-77 degrees Fahrenheit), a new study published today in eLife shows.

15 Sep 2020

Study reveals damaging role of immune system in severe brain infection

A new study has detailed the damaging role played by the immune system in a severe brain condition most commonly caused by the cold sore virus.

15 Sep 2020

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their medicine as prescribed, say Henry Ford Health System dermatology researchers in a study published in the Journal of the American Academy of Dermatology.

15 Sep 2020

Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer

A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.

14 Sep 2020

Oxford University and AstraZeneca resume COVID-19 vaccine trial

More than a hundred candidate vaccine trials against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), are underway. About 35 are now undergoing clinical evaluation, and of these, nine are in the final phase of human trials, including the vaccine developed by Oxford University and the biopharmaceutical firm, AstraZeneca.

14 Sep 2020

Researchers identify microRNA molecules that could repress the replication of human coronaviruses

HSE University researchers have found microRNA molecules that are potentially capable of repressing the replication of human coronaviruses, including SARS-CoV-2.

14 Sep 2020

Regular cannabis use does not appear to increase pain sensitivity, study suggests

A recent study examining pain among cannabis users suggests that--unlike long-term opioid use--regular cannabis use does not appear to increase pain sensitivity.

10 Sep 2020

Neuronal connections that trigger insomnia tied to stress-induced changes in the immune system

Scientists at Cold Spring Harbor Laboratory and Stanford University have pinpointed the circuit in the brain that is responsible for sleepless nights in times of stress--and it turns out that circuit does more than make you toss and turn.

10 Sep 2020

Study: Small proteins block interaction between SARS-CoV-2 and human cell receptor

Using innovative computer-based approaches, researchers have developed protein inhibitors that block the interaction between the SARS-CoV-2 virus and human cell receptor ACE2.

10 Sep 2020

Host gene editing main driving force of SARS-CoV-2 mutations

A new study published on the aRxiv preprint server in September 2020 shows that the host immune response, mediated by two RNA editors, causes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to adapt and change strain characteristics.

9 Sep 2020

Warm weather increases human mobility, and SARS-CoV-2 transmission

A recent study published in the preprint server medRxiv in September 2020 shows that the effect of climatic factors such as temperature and humidity is mediated mostly through human mobility. Thus, human behavioral changes are still the mainstay of containment rather than hoping for weather conditions to keep the virus at bay.

9 Sep 2020

AstraZeneca COVID-19 vaccine trial paused due to suspected adverse reaction

The coronavirus disease (COVID-19) pandemic is rippling across the globe, with over 27.47 million reported cases. With the vast spread of the virus, scientists are racing to gain the approval of candidate vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 disease and Multisystem Inflammatory Syndrome in Children (MIS-C).

8 Sep 2020

Six genomics research projects receive grants to address the role of ethnicity in major cancers

Leading cancer scientists working with the New York Genome Center (NYGC) announced today that grants are being awarded to fund six projects that address the role of ethnicity in several major cancer types, taking advantage of the diversity of patients being treated at health care institutions throughout the New York City area.

8 Sep 2020

Pooled saliva testing increases COVID-19 testing capacity

Now, a new study by researchers at Yale School of Medicine and published on the preprint server medRxiv in September 2020 shows that pooled saliva samples can save resources and increase testing capacity, making a significant difference in the management of the pandemic.

7 Sep 2020

Antibody responses against seasonal common cold coronaviruses may protect against SARS-CoV-2

With the use of an accurate high throughput assay, researchers from the Weizmann Institute of Science and Magen David Adom Blood Services in Israel showed substantial inter-individual variability and antibody cross-reactivity against seasonal coronaviruses upon SARS-CoV-2 infection, with important implications for immune surveys and vaccines. The study is currently available on the medRxiv* preprint server.

6 Sep 2020

Early-phase Russian trials reveal safety and immunogenicity of two formulations of a two-part vaccine

Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.

5 Sep 2020

Will Labor Day weekend bring another holiday COVID surge? Jury’s out.

Hopefully, summer won’t end the way it began. Memorial Day celebrations helped set off a wave of coronavirus infections across much of the South and West. Gatherings around the Fourth of July seemed to keep those hot spots aflame.

4 Sep 2020

COVID-19 vaccine candidate protects animals against SARS-CoV-2

Most people with COVID-19 have relatively mild disease, but a subset of people develop severe pneumonia and respiratory failure, potentially leading to death.

3 Sep 2020

Cold News and Research

A novel method for 3D printing of milk-based products

Johns Hopkins professor to study how climate and environmental elements influence the spread of COVID-19

Climate change could shift the spread of West Nile virus

Study reveals damaging role of immune system in severe brain infection

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer

Oxford University and AstraZeneca resume COVID-19 vaccine trial

Researchers identify microRNA molecules that could repress the replication of human coronaviruses

Regular cannabis use does not appear to increase pain sensitivity, study suggests

Neuronal connections that trigger insomnia tied to stress-induced changes in the immune system

Study: Small proteins block interaction between SARS-CoV-2 and human cell receptor

Host gene editing main driving force of SARS-CoV-2 mutations

Warm weather increases human mobility, and SARS-CoV-2 transmission

AstraZeneca COVID-19 vaccine trial paused due to suspected adverse reaction

Six genomics research projects receive grants to address the role of ethnicity in major cancers

Pooled saliva testing increases COVID-19 testing capacity

Antibody responses against seasonal common cold coronaviruses may protect against SARS-CoV-2

Early-phase Russian trials reveal safety and immunogenicity of two formulations of a two-part vaccine

Will Labor Day weekend bring another holiday COVID surge? Jury’s out.

COVID-19 vaccine candidate protects animals against SARS-CoV-2

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News